Literature DB >> 16623851

Variations in the human cannabinoid receptor (CNR1) gene modulate striatal responses to happy faces.

Bhismadev Chakrabarti1, Lindsey Kent, John Suckling, Edward Bullmore, Simon Baron-Cohen.   

Abstract

Happy facial expressions are innate social rewards and evoke a response in the striatum, a region known for its role in reward processing in rats, primates and humans. The cannabinoid receptor 1 (CNR1) is the best-characterized molecule of the endocannabinoid system, involved in processing rewards. We hypothesized that genetic variation in human CNR1 gene would predict differences in the striatal response to happy faces. In a 3T functional magnetic resonance imaging (fMRI) scanning study on 19 Caucasian volunteers, we report that four single nucleotide polymorphisms (SNPs) in the CNR1 locus modulate differential striatal response to happy but not to disgust faces. This suggests a role for the variations of the CNR1 gene in underlying social reward responsivity. Future studies should aim to replicate this finding with a balanced design in a larger sample, but these preliminary results suggest neural responsivity to emotional and socially rewarding stimuli varies as a function of CNR1 genotype. This has implications for medical conditions involving hypo-responsivity to emotional and social stimuli, such as autism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16623851     DOI: 10.1111/j.1460-9568.2006.04697.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  45 in total

Review 1.  [Neurogenetics of emotional processes. Neuroimaging findings as endophenotypes for depression].

Authors:  U Dannlowski; C Konrad; V Arolt; T Suslow
Journal:  Nervenarzt       Date:  2010-01       Impact factor: 1.214

2.  Reward circuitry function in autism during face anticipation and outcomes.

Authors:  Gabriel S Dichter; J Anthony Richey; Alison M Rittenberg; Antoinette Sabatino; James W Bodfish
Journal:  J Autism Dev Disord       Date:  2012-02

Review 3.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

4.  Genetic and Environmental Factors Associated with Cannabis Involvement.

Authors:  Ryan Bogdan; Jonathan Ma Winstone; Arpana Agrawal
Journal:  Curr Addict Rep       Date:  2016-04-12

5.  Emotional face identification in youths with primary bipolar disorder or primary attention-deficit/hyperactivity disorder.

Authors:  Karen E Seymour; Matthew F Pescosolido; Brooke L Reidy; Thania Galvan; Kerri L Kim; Matthew Young; Daniel P Dickstein
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-05       Impact factor: 8.829

Review 6.  Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.

Authors:  C J Hillard; K M Weinlander; K L Stuhr
Journal:  Neuroscience       Date:  2011-11-17       Impact factor: 3.590

Review 7.  Cannabis and psychosis/schizophrenia: human studies.

Authors:  Deepak Cyril D'Souza; Richard Andrew Sewell; Mohini Ranganathan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-16       Impact factor: 5.270

Review 8.  The neurobiology of individual differences in complex behavioral traits.

Authors:  Ahmad R Hariri
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

9.  Probing reward function in posttraumatic stress disorder: expectancy and satisfaction with monetary gains and losses.

Authors:  James W Hopper; Roger K Pitman; Zhaohui Su; Gene M Heyman; Natasha B Lasko; Michael L Macklin; Scott P Orr; Scott E Lukas; Igor Elman
Journal:  J Psychiatr Res       Date:  2008-02-20       Impact factor: 4.791

10.  Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function.

Authors:  Ahmad R Hariri; Adam Gorka; Luke W Hyde; Mark Kimak; Indrani Halder; Francesca Ducci; Robert E Ferrell; David Goldman; Stephen B Manuck
Journal:  Biol Psychiatry       Date:  2008-12-21       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.